![]() | ||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 99.2 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| ENTEGRIS, INC. | ||||||||
| Dated: October 26, 2021 | By: | /s/ Gregory B. Graves | ||||||
| Name: | Gregory B. Graves | |||||||
| Title: | Executive Vice President and Chief Financial Officer | |||||||
![]() | PRESS RELEASE Bill Seymour VP of Investor Relations T + 1 952 556 1844 | |||||||||||||
| GAAP Results | October 2, 2021 | September 26, 2020 | July 3, 2021 | ||||||||
| Net sales | $579,493 | $480,987 | $571,352 | ||||||||
| Operating income | $139,357 | $106,761 | $138,889 | ||||||||
| Operating margin - as a % of net sales | 24.0 | % | 22.2 | % | 24.3 | % | |||||
| Net income | $117,461 | $79,303 | $88,770 | ||||||||
| Diluted earnings per common share | $0.86 | $0.58 | $0.65 | ||||||||
| Non-GAAP Results | |||||||||||
| Non-GAAP adjusted operating income | $152,696 | $121,612 | $151,603 | ||||||||
| Non-GAAP adjusted operating margin - as a % of net sales | 26.3 | % | 25.3 | % | 26.5 | % | |||||
| Non-GAAP net income | $125,383 | $91,460 | $116,711 | ||||||||
| Diluted non-GAAP earnings per common share | $0.92 | $0.67 | $0.85 | ||||||||
| Three months ended | ||||||||||||||
| October 2, 2021 | September 26, 2020 | July 3, 2021 | ||||||||||||
| Net sales | $579,493 | $480,987 | $571,352 | |||||||||||
| Cost of sales | 315,289 | 254,987 | 305,968 | |||||||||||
| Gross profit | 264,204 | 226,000 | 265,384 | |||||||||||
| Selling, general and administrative expenses | 71,032 | 71,195 | 72,621 | |||||||||||
| Engineering, research and development expenses | 41,972 | 36,295 | 41,972 | |||||||||||
| Amortization of intangible assets | 11,843 | 11,749 | 11,902 | |||||||||||
| Operating income | 139,357 | 106,761 | 138,889 | |||||||||||
| Interest expense, net | 9,339 | 12,651 | 10,643 | |||||||||||
| Other expense (income), net | 1,917 | (1,752) | 23,560 | |||||||||||
| Income before income tax expense | 128,101 | 95,862 | 104,686 | |||||||||||
| Income tax expense | 10,640 | 16,559 | 15,916 | |||||||||||
| Net income | $117,461 | $79,303 | $88,770 | |||||||||||
| Basic earnings per common share: | $0.87 | $0.59 | $0.66 | |||||||||||
| Diluted earnings per common share: | $0.86 | $0.58 | $0.65 | |||||||||||
| Weighted average shares outstanding: | ||||||||||||||
| Basic | 135,583 | 134,957 | 135,498 | |||||||||||
| Diluted | 136,631 | 136,252 | 136,533 | |||||||||||
| Nine months ended | |||||||||||
| October 2, 2021 | September 26, 2020 | ||||||||||
| Net sales | $1,663,689 | $1,341,719 | |||||||||
| Cost of sales | 899,115 | 722,869 | |||||||||
| Gross profit | 764,574 | 618,850 | |||||||||
| Selling, general and administrative expenses | 215,042 | 196,958 | |||||||||
| Engineering, research and development expenses | 121,692 | 98,499 | |||||||||
| Amortization of intangible assets | 35,616 | 41,176 | |||||||||
| Operating income | 392,224 | 282,217 | |||||||||
| Interest expense, net | 31,563 | 35,681 | |||||||||
| Other expense (income), net | 29,807 | (1,351) | |||||||||
| Income before income tax expense | 330,854 | 247,887 | |||||||||
| Income tax expense | 39,947 | 39,542 | |||||||||
| Net income | $290,907 | $208,345 | |||||||||
| Basic earnings per common share: | $2.15 | $1.55 | |||||||||
| Diluted earnings per common share: | $2.13 | $1.53 | |||||||||
| Weighted average shares outstanding: | |||||||||||
| Basic | 135,383 | 134,801 | |||||||||
| Diluted | 136,556 | 136,209 | |||||||||
| October 2, 2021 | December 31, 2020 | ||||||||||||||||
| ASSETS | |||||||||||||||||
| Current assets: | |||||||||||||||||
| Cash and cash equivalents | $475,752 | $580,893 | |||||||||||||||
| Trade accounts and notes receivable, net | 315,073 | 264,392 | |||||||||||||||
| Inventories, net | 429,016 | 323,944 | |||||||||||||||
| Deferred tax charges and refundable income taxes | 21,760 | 21,136 | |||||||||||||||
| Other current assets | 34,104 | 43,892 | |||||||||||||||
| Total current assets | 1,275,705 | 1,234,257 | |||||||||||||||
| Property, plant and equipment, net | 597,630 | 525,367 | |||||||||||||||
| Other assets: | |||||||||||||||||
| Right-of-use assets | 56,990 | 45,924 | |||||||||||||||
| Goodwill | 749,933 | 748,037 | |||||||||||||||
| Intangible assets, net | 302,487 | 337,632 | |||||||||||||||
| Deferred tax assets and other noncurrent tax assets | 17,565 | 14,519 | |||||||||||||||
| Other | 11,965 | 11,960 | |||||||||||||||
| Total assets | $3,012,275 | $2,917,696 | |||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||||
| Current liabilities | |||||||||||||||||
| Accounts payable | $120,611 | $81,618 | |||||||||||||||
| Accrued liabilities | 181,813 | 177,012 | |||||||||||||||
| Income tax payable | 6,989 | 43,996 | |||||||||||||||
| Total current liabilities | 309,413 | 302,626 | |||||||||||||||
| Long-term debt, excluding current maturities | 936,704 | 1,085,783 | |||||||||||||||
| Long-term lease liability | 52,486 | 39,730 | |||||||||||||||
| Other liabilities | 102,892 | 110,063 | |||||||||||||||
| Shareholders’ equity | 1,610,780 | 1,379,494 | |||||||||||||||
| Total liabilities and equity | $3,012,275 | $2,917,696 | |||||||||||||||
| Three months ended | Nine months ended | |||||||||||||
| October 2, 2021 | September 26, 2020 | October 2, 2021 | September 26, 2020 | |||||||||||
| Operating activities: | ||||||||||||||
| Net income | $117,461 | $79,303 | $290,907 | $208,345 | ||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||
| Depreciation | 22,841 | 20,777 | 67,510 | 62,064 | ||||||||||
| Amortization | 11,843 | 11,749 | 35,616 | 41,176 | ||||||||||
| Stock-based compensation expense | 7,467 | 5,903 | 22,124 | 16,552 | ||||||||||
| Loss on extinguishment of debt and modification | — | 908 | 23,338 | 2,378 | ||||||||||
| Other | (1,773) | 19,302 | (1,976) | 30,727 | ||||||||||
| Changes in operating assets and liabilities, net of effects of acquisitions: | ||||||||||||||
| Trade accounts and notes receivable | (5,127) | (23,280) | (53,358) | (65,367) | ||||||||||
| Inventories | (45,464) | 1,084 | (115,187) | (54,278) | ||||||||||
| Accounts payable and accrued liabilities | 52,924 | 4,433 | 37,577 | 10,076 | ||||||||||
| Income taxes payable, refundable income taxes and noncurrent taxes payable | (8,833) | (16,407) | (35,275) | (11,995) | ||||||||||
| Other | (1,835) | (2,540) | 13,198 | 2,978 | ||||||||||
| Net cash provided by operating activities | 149,504 | 101,232 | 284,474 | 242,656 | ||||||||||
| Investing activities: | ||||||||||||||
| Acquisition of property and equipment | (48,885) | (32,687) | (133,986) | (79,560) | ||||||||||
| Acquisition of business, net of cash acquired | — | (35,500) | (2,250) | (111,145) | ||||||||||
| Other | 4,326 | 54 | 4,416 | 265 | ||||||||||
| Net cash used in investing activities | (44,559) | (68,133) | (131,820) | (190,440) | ||||||||||
| Financing activities: | ||||||||||||||
| Proceeds from revolving credit facility and long-term debt | — | — | 451,000 | 617,000 | ||||||||||
| Payments of revolving credit facility and long-term debt | — | (100,000) | (601,000) | (468,000) | ||||||||||
| Payments for debt extinguishment costs | — | — | (19,080) | — | ||||||||||
| Payments for dividends | (10,853) | (10,794) | (32,650) | (32,446) | ||||||||||
| Issuance of common stock | 1,055 | 3,150 | 17,872 | 4,899 | ||||||||||
| Taxes paid related to net share settlement of equity awards | (275) | (11,836) | (15,368) | (24,556) | ||||||||||
| Repurchase and retirement of common stock | (20,000) | — | (50,000) | (29,564) | ||||||||||
| Deferred acquisition payments | — | — | — | (16,125) | ||||||||||
| Other | (486) | (1) | (5,287) | (6,856) | ||||||||||
| Net cash (used in) provided by financing activities | (30,559) | (119,481) | (254,513) | 44,352 | ||||||||||
| Effect of exchange rate changes on cash and cash equivalents | 333 | 1,687 | (3,282) | (507) | ||||||||||
| Increase (decrease) in cash and cash equivalents | 74,719 | (84,695) | (105,141) | 96,061 | ||||||||||
| Cash and cash equivalents at beginning of period | 401,033 | 532,667 | 580,893 | 351,911 | ||||||||||
| Cash and cash equivalents at end of period | $475,752 | $447,972 | $475,752 | $447,972 | ||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| Net sales | October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | |||||||||||||||
| Specialty Chemicals and Engineered Materials | $176,380 | $150,480 | $180,366 | $523,287 | $440,907 | |||||||||||||||
| Microcontamination Control | 225,877 | 193,541 | 227,521 | 660,497 | 536,560 | |||||||||||||||
| Advanced Materials Handling | 186,200 | 144,370 | 172,502 | 507,243 | 386,941 | |||||||||||||||
| Inter-segment elimination | (8,964) | (7,404) | (9,037) | (27,338) | (22,689) | |||||||||||||||
| Total net sales | $579,493 | $480,987 | $571,352 | $1,663,689 | $1,341,719 | |||||||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| Segment profit | October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | |||||||||||||||
| Specialty Chemicals and Engineered Materials | $41,091 | $32,600 | $44,945 | $120,592 | $98,208 | |||||||||||||||
| Microcontamination Control | 78,399 | 64,915 | 78,132 | 227,097 | 177,219 | |||||||||||||||
| Advanced Materials Handling | 40,503 | 33,266 | 42,093 | 114,691 | 76,707 | |||||||||||||||
| Total segment profit | 159,993 | 130,781 | 165,170 | 462,380 | 352,134 | |||||||||||||||
| Amortization of intangibles | 11,843 | 11,749 | 11,902 | 35,616 | 41,176 | |||||||||||||||
| Unallocated expenses | 8,793 | 12,271 | 14,379 | 34,540 | 28,741 | |||||||||||||||
| Total operating income | $139,357 | $106,761 | $138,889 | $392,224 | $282,217 | |||||||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | ||||||||||||||||
| Net sales | $579,493 | $480,987 | $571,352 | $1,663,689 | $1,341,719 | |||||||||||||||
| Gross profit-GAAP | $264,204 | $226,000 | $265,384 | $764,574 | $618,850 | |||||||||||||||
| Adjustments to gross profit: | ||||||||||||||||||||
| Integration costs | — | — | — | — | (1,557) | |||||||||||||||
| Severance and restructuring costs | — | — | — | — | 465 | |||||||||||||||
| Charge for fair value mark-up of acquired inventory sold | — | 229 | — | — | 590 | |||||||||||||||
| Adjusted gross profit | $264,204 | $226,229 | $265,384 | $764,574 | $618,348 | |||||||||||||||
| Gross margin - as a % of net sales | 45.6 | % | 47.0 | % | 46.4 | % | 46.0 | % | 46.1 | % | ||||||||||
| Adjusted gross margin - as a % of net sales | 45.6 | % | 47.0 | % | 46.4 | % | 46.0 | % | 46.1 | % | ||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| Segment profit-GAAP | October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | |||||||||||||||
| Specialty Chemicals and Engineered Materials (SCEM) | $41,091 | $32,600 | $44,945 | $120,592 | $98,208 | |||||||||||||||
| Microcontamination Control (MC) | 78,399 | 64,915 | 78,132 | 227,097 | 177,219 | |||||||||||||||
| Advanced Materials Handling (AMH) | 40,503 | 33,266 | 42,093 | 114,691 | 76,707 | |||||||||||||||
| Total segment profit | 159,993 | 130,781 | 165,170 | 462,380 | 352,134 | |||||||||||||||
| Amortization of intangible assets | 11,843 | 11,749 | 11,902 | 35,616 | 41,176 | |||||||||||||||
| Unallocated expenses | 8,793 | 12,271 | 14,379 | 34,540 | 28,741 | |||||||||||||||
| Total operating income | $139,357 | $106,761 | $138,889 | $392,224 | $282,217 | |||||||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| Adjusted segment profit | October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | |||||||||||||||
| SCEM segment profit | $41,091 | $32,600 | $44,945 | $120,592 | $98,208 | |||||||||||||||
| Integration costs | — | — | — | — | (1,557) | |||||||||||||||
| Severance and restructuring costs | 69 | 277 | 51 | 167 | 906 | |||||||||||||||
| Charge for fair value write-up of acquired inventory sold | — | — | — | — | 235 | |||||||||||||||
| SCEM adjusted segment profit | $41,160 | $32,877 | $44,996 | $120,759 | $97,792 | |||||||||||||||
| MC segment profit | $78,399 | $64,915 | $78,132 | $227,097 | $177,219 | |||||||||||||||
| Severance and restructuring costs | 75 | 301 | 55 | 181 | 985 | |||||||||||||||
| Charge for fair value write-up of acquired inventory sold | — | — | — | — | 126 | |||||||||||||||
| MC adjusted segment profit | $78,474 | $65,216 | $78,187 | $227,278 | $178,330 | |||||||||||||||
| AMH segment profit | $40,503 | $33,266 | $42,093 | $114,691 | $76,707 | |||||||||||||||
| Severance and restructuring costs | 52 | 213 | 38 | 127 | 1,162 | |||||||||||||||
| Charge for fair value write-up of acquired inventory sold | — | 229 | — | — | 229 | |||||||||||||||
| AMH adjusted segment profit | $40,555 | $33,708 | $42,131 | $114,818 | $78,098 | |||||||||||||||
| Unallocated general and administrative expenses | $8,793 | $12,271 | $14,379 | $34,540 | $28,741 | |||||||||||||||
| Unallocated deal and integration costs | (1,290) | (1,902) | (632) | (3,966) | (5,796) | |||||||||||||||
| Unallocated severance and restructuring costs | (10) | (180) | (36) | (54) | (810) | |||||||||||||||
| Adjusted unallocated general and administrative expenses | $7,493 | $10,189 | $13,711 | $30,520 | $22,135 | |||||||||||||||
| Total adjusted segment profit | $160,189 | $131,801 | $165,314 | $462,855 | $354,220 | |||||||||||||||
| Adjusted amortization of intangible assets | — | — | — | — | — | |||||||||||||||
| Adjusted unallocated general and administrative expenses | 7,493 | 10,189 | 13,711 | 30,520 | 22,135 | |||||||||||||||
| Total adjusted operating income | $152,696 | $121,612 | $151,603 | $432,335 | $332,085 | |||||||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | ||||||||||||||||
| Net sales | $579,493 | $480,987 | $571,352 | $1,663,689 | $1,341,719 | |||||||||||||||
| Net income | $117,461 | $79,303 | $88,770 | $290,907 | $208,345 | |||||||||||||||
| Net income - as a % of net sales | 20.3 | % | 16.5 | % | 15.5 | % | 17.5 | % | 15.5 | % | ||||||||||
| Adjustments to net income: | ||||||||||||||||||||
| Income tax expense | 10,640 | 16,559 | 15,916 | 39,947 | 39,542 | |||||||||||||||
| Interest expense, net | 9,339 | 12,651 | 10,643 | 31,563 | 35,681 | |||||||||||||||
| Other expense (income), net | 1,917 | (1,752) | 23,560 | 29,807 | (1,351) | |||||||||||||||
| GAAP - Operating income | 139,357 | 106,761 | 138,889 | 392,224 | 282,217 | |||||||||||||||
| Operating margin - as a % of net sales | 24.0 | % | 22.2 | % | 24.3 | % | 23.6 | % | 21.0 | % | ||||||||||
| Charge for fair value write-up of acquired inventory sold | — | 229 | — | — | 590 | |||||||||||||||
| Deal and transaction costs | — | 642 | — | — | 2,576 | |||||||||||||||
| Integration costs | 1,290 | 1,260 | 632 | 3,966 | 1,663 | |||||||||||||||
| Severance and restructuring costs | 206 | 971 | 180 | 529 | 3,863 | |||||||||||||||
| Amortization of intangible assets | 11,843 | 11,749 | 11,902 | 35,616 | 41,176 | |||||||||||||||
| Adjusted operating income | 152,696 | 121,612 | 151,603 | 432,335 | 332,085 | |||||||||||||||
| Adjusted operating margin - as a % of net sales | 26.3 | % | 25.3 | % | 26.5 | % | 26.0 | % | 24.8 | % | ||||||||||
| Depreciation | 22,841 | 20,777 | 22,574 | 67,510 | 62,064 | |||||||||||||||
| Adjusted EBITDA | $175,537 | $142,389 | $174,177 | $499,845 | $394,149 | |||||||||||||||
| Adjusted EBITDA - as a % of net sales | 30.3 | % | 29.6 | % | 30.5 | % | 30.0 | % | 29.4 | % | ||||||||||
| Three months ended | Nine months ended | |||||||||||||||||||
| October 2, 2021 | September 26, 2020 | July 3, 2021 | October 2, 2021 | September 26, 2020 | ||||||||||||||||
| GAAP net income | $117,461 | $79,303 | $88,770 | $290,907 | $208,345 | |||||||||||||||
| Adjustments to net income: | ||||||||||||||||||||
| Charge for fair value write-up of inventory acquired | — | 229 | — | — | 590 | |||||||||||||||
| Deal and transaction costs | — | 642 | — | — | 2,576 | |||||||||||||||
| Integration costs | 1,290 | 1,260 | 632 | 3,966 | 1,663 | |||||||||||||||
| Severance and restructuring costs | 206 | 971 | 180 | 529 | 3,863 | |||||||||||||||
| Loss on extinguishment of debt and modification | — | 908 | 23,338 | 23,338 | 2,378 | |||||||||||||||
| Amortization of intangible assets | 11,843 | 11,749 | 11,902 | 35,616 | 41,176 | |||||||||||||||
Tax effect of adjustments to net income and discrete items1 | (5,417) | (3,602) | (8,111) | (16,749) | (11,979) | |||||||||||||||
| Non-GAAP net income | $125,383 | $91,460 | $116,711 | $337,607 | $248,612 | |||||||||||||||
| Diluted earnings per common share | $0.86 | $0.58 | $0.65 | $2.13 | $1.53 | |||||||||||||||
| Effect of adjustments to net income | $0.06 | $0.09 | $0.20 | $0.34 | $0.30 | |||||||||||||||
| Diluted non-GAAP earnings per common share | $0.92 | $0.67 | $0.85 | $2.47 | $1.83 | |||||||||||||||
| Fourth-Quarter Outlook | |||||
| Reconciliation GAAP net income to non-GAAP net income | December 31, 2021 | ||||
| GAAP net income | $109 - $116 | ||||
| Adjustments to net income: | |||||
| Restructuring and integration costs | 2 | ||||
| Amortization of intangible assets | 10 | ||||
| Income tax effect | (2) | ||||
| Non-GAAP net income | $119 - $126 | ||||
| Fourth-Quarter Outlook | |||||
| Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share | December 31, 2021 | ||||
| Diluted earnings per common share | $0.80 - $0.85 | ||||
| Adjustments to diluted earnings per common share: | |||||
| Restructuring and integration costs | 0.01 | ||||
| Amortization of intangible assets | 0.08 | ||||
| Income tax effect | (0.02) | ||||
| Diluted non-GAAP earnings per common share | $0.87 - $0.92 | ||||